NORTH
02 Dec 2020
NORTH
ACTRN12618000321246
A phase II study study of panobinostat in paediatric, adolescent and young adult patients with solid tumours including osteosarcoma, malignant rhaboidntumour/ atypical teratoid rhabdoid tumours and neuroblastoma.
ANZCHOG
Cancer Type | Other |
---|---|
Trial Type | Treatment |
Phase | Phase II |
Age Range | Under 40 years of age |
Sex | Both |
Tumour Stream | - |
Cancer Stage | All stages |
Anticipated Start Date | 2018-03-05 |
Anticipated End Date | - |
Hospital | Royal Adelaide Hospital |
---|---|
Clinical Trial Coordinator | Anne Milton |
anne.milton@sa.gov.au | |
Phone | 08 7074 2342 |
Principal Investigator | Nimit Singhal |
Recruitment Status | Recruiting |